Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Oestrogen receptor positive breast cancer
0.040 Biomarker disease BEFREE Clinical trials with newly developed RET inhibitors are needed to evaluate if RET inhibition has a beneficial impact on patient survival in ER positive breast cancer. 30621641 2019
Oestrogen receptor positive breast cancer
0.040 Biomarker disease BEFREE ER-positive breast cancer cells are poised for RET-mediated endocrine resistance. 29608602 2018
Oestrogen receptor positive breast cancer
0.040 Biomarker disease BEFREE Targeting the receptor tyrosine kinase RET in combination with aromatase inhibitors in ER positive breast cancer xenografts. 27602955 2016
Oestrogen receptor positive breast cancer
0.040 Biomarker disease BEFREE These results demonstrate a novel pathway of ER and FOXA1 transcription factor crosstalk in regulating RET/PTC kinase expression, and demonstrate that RET/PTC kinase is a critical regulator for the proliferation of ER-positive breast cancer cells. 21947652 2012